Business News

Insights and Prediction of Dry Powder Inhalers Global Market Report (2019-2026)

Insights and Prediction of Dry Powder Inhalers Global Market Report (2019-2026)

The newly Dry Powder Inhalers market report provided a complete view of the present and future market. Deep analysis of enterprise competition pattern, enterprise product advantages and disadvantages, regional industrial layout characteristics. The base year considered for the study is 2018 and the market size is projected from 2019 to 2026.

Product Information

A dry powder inhaler (DPI) is a device which delivers medication to the lungs of patients suffering from respiratory disorders in the form of a dry powder. Dry powder inhaler is used to treat respiratory diseases such as asthma, bronchitis, emphysema, etc. DPI are better alternatives to conventional inhalers such as metered-dose inhalers. The dry powder inhaler is breath-activated, where the drug or medicine is released to the lungs only after taking a fast-deep breath through the inhaler.

Based on products, the various types include Capsule based, Blister based, Reservoir/Cartridge based, and Others. The capsule based devices segment is expected to dominate the global dry powder inhalers market during the forecast period, owing to increase in a number of manufacturers offering diverse products in the segment and rise in adoption and preference of health care providers and patients for these devices.

Based on application, the Dry Powder Inhalers market is segmented into Hospitals and pharmacies, Retail pharmacies, Drug stores, and Others. Hospital and pharmacies will continue to be the main distribution channel for dry powder inhalers, with sales expected to surpass 150,000 Mn units by the end of 2026.

Get FREE Sample of Dry Powder Inhalers Market Report at:

https://www.globalmarketmonitor.com/reports/142568-dry-powder-inhalers-market-report-2018.html#download-sample

Market Insights

According to a new research study, the Dry Powder Inhalers market size is expected to reach USD 305 million by 2026 from USD 218 million in 2019, with a compound annual growth rate of 4.9% during the forecast period.

Increasing incidence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, etc. across the globe is a major factor driving the growth of the global dry powder inhaler market. Demand for cost-effective devices for the treatment of respiratory disorders among the users is another factor expected to support the growth of the market. Furthermore, advancements such as the development of dry powder inhaler that provides the high dose and systemic delivery of medications into lungs are projected to create potential revenue opportunities to players operating in the global dry powder inhaler market.

However, high cost of device is a major factor restraining growth of the global dry powder inhaler market. In addition, stringent government regulations related to device approval is also another factor projected to restrain the dry powder inhaler market’s growth.

Regional Segment Analysis

The report focuses on detailed analysis of major regions like North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia), and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).

Asia-Pacific is the largest sales volume market for Dry Powder Inhalers, with a revenue market share nearly 38% in 2018. This was followed by North America and Europe, accounting for 30% and 20% respectively. The market in the Asia Pacific accounted for the largest revenue share in 2018 and is projected to witness the highest CAGR in terms of revenue over the forecast period. This can be attributed to rising demand for cost-effective respiratory devices. Additionally, rising disposable income, increasing investments for the development of healthcare sector in emerging economies such as China, Japan, and India are anticipated to further impel the growth of the Asia Pacific market in the near future.

North America market held a second-largest revenue share in the global market in terms of revenue, owing to increasing incidences of chronic respiratory diseases such as asthma, bronchitis, and many more. In addition, the significant presence of prominent players operating in the market in this region is another factor contributing to growth in North America. Europe market accounted for third-largest revenue share in the global market, followed by markets in Latin America, and the Middle East & Africa respectively.

Purchase a copy of Dry Powder Inhalers report at:

https://www.globalmarketmonitor.com/reports/142568-dry-powder-inhalers-market-report-2018.html#report-inquiry

Competitive Players

Major players in the global dry powder inhaler market are committed to developing new generation products.  These market players are investing in R&D activities apropos to novel device architectures, powder formulations, and particle engineering. The development of enhanced particle characteristics and high-efficiency inhaler design is expected to remain the main strategy of market participants.

The Dry Powder Inhalers market is full of competition due to the presence of many large and small companies and local manufacturers. The leading vendors in the market are 3M, Aerovance, AstraZeneca, Boehringer Ingelheim, and Chiesi. Other prominent vendors in the market are Cipla, Civitas/Alkermes, GlaxoSmithKline, Hovione, Mannkind, Mantecorp, Meda, MicroDose Therapeutx, Novartis, Orion, PH&T S.p.A, Respirics, S.M.B., and others.

Target Audience for this Report

  • Dry Powder Inhalers manufacturers
  • Dry Powder Inhalers importers and exporters
  • Dry Powder Inhalers traders, distributors, and suppliers
  • Dry Powder Inhalers industry associations
  • Product managers, Dry Powder Inhalers industry administrator, C-level executives of the industries
  • Market Research and consulting firms
  • Healthcare organizations
  • Research & Clinical Laboratories

Ask for a discount at:

https://www.globalmarketmonitor.com/reports/142568-dry-powder-inhalers-market-report-2018.html#report-inquiry

Table of Content

1 Report Overview

1.1  Product Definition and Scope

1.2  PEST (Political, Economic, Social and Technological) Analysis of Dry Powder Inhalers Market

2 Market Trends and Competitive Landscape

3 Segmentation of Dry Powder Inhalers Market by Types

4 Segmentation of Dry Powder Inhalers Market by End-Users

5 Market Analysis by Major Regions

6 Product Commodity of Dry Powder Inhalers Market in Major Countries

7 North America Dry Powder Inhalers Landscape Analysis

8 Europe Dry Powder Inhalers Landscape Analysis

9 Asia Pacific Dry Powder Inhalers Landscape Analysis

10 Latin America, Middle East & Africa Dry Powder Inhalers Landscape Analysis  

11 Major Players Profile

11.1 3M

11.1.1 3M Company Profile and Recent Development

11.1.2 Market Performance

11.1.3 Product and Service Introduction

11.2 Aerovance

11.3 AstraZeneca

11.4 Boehringer Ingelheim

11.5 Chiesi

11.6 Cipla

11.7 Civitas/Alkermes

11.8 GlaxoSmithKline

11.9 Hovione

11.10 Mannkind

11.11 Mantecorp

11.12 Meda

11.13 MicroDose Therapeutx

11.14 Novartis

11.15 Orion

11.16 PH&T S.p.A

11.17 Respirics

11.18 S.M.B.

Contact:

Global Market Monitor

One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,

NY 11201, USA

Name: Rebecca Hall

Phone: + 1 (347) 467 7721

Email: info@globalmarketmonitor.com

Web Site: https://www.globalmarketmonitor.com